dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.creatorPinheiro, R. F.
dc.creatorSilva, MRR
dc.creatorChauffaille, MDF
dc.date.accessioned2016-01-24T12:41:04Z
dc.date.accessioned2022-10-07T21:25:15Z
dc.date.available2016-01-24T12:41:04Z
dc.date.available2022-10-07T21:25:15Z
dc.date.created2016-01-24T12:41:04Z
dc.date.issued2006-04-01
dc.identifierLeukemia Research. Oxford: Pergamon-Elsevier B.V., v. 30, n. 4, p. 507-510, 2006.
dc.identifier0145-2126
dc.identifierhttp://repositorio.unifesp.br/handle/11600/28819
dc.identifier10.1016/j.leukres.2005.08.025
dc.identifierWOS:000236086200020
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4029235
dc.description.abstractMyelodysplastic syndrome is a clonal hematopoietic stem cell disorder characterized by ineffective hematopoiesis, peripheral cytopenias and an additional risk to evolve to acute leukemia in up to 30% of the cases. Autoimmune manifestations as vasculitis, pyoderma gangrenosum, hemolytic anemia, immune thrombocytopenia, rheumatoid arthritis as well as positive anti-nuclear factor and rheumatoid factor have been reported in 13-30% of MDS patients. the aim of this report is to present three patients with 5q- syndrome who presented different autoimmune, serological and clinical phenomena and review the literature. Patient I showed a focal and segmental glomerulosclerosis (FSGE) in the course of a MDS. Renal involvement in MDS as autoimmune phenomenon is rare and few reports have documented different forms of glomerular diseases in adults with MDS. Patients 2 and 3 showed a rheumatoid factor of 1/140 and the direct Coomb's test positive (3+), respectively, but without evidence of clinical autoimmune manifestation.In conclusion, patients with the 5q- syndrome experience a relative benign disease course extending over several years. We believe that careful follow-up of patients with autoimmune manifestations as here reported is important to detect any unexpected outcome. (C) 2005 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationLeukemia Research
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.rightsAcesso restrito
dc.subjectmyelodysplatic syndrome
dc.subject5q
dc.subjectsyndrome
dc.subjectautoimmune manifestations
dc.titleThe 5q-syndrome and autoimmune phenomena: Report of three cases
dc.typeArtigo


Este ítem pertenece a la siguiente institución